Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000051

Chief Financial Officer acquired 88,878 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barnett Eva Renee Chief Financial Officer 2025-04-01 Grant or award +88,878 410,830 D
Derivatives
Barnett Eva Renee Chief Financial Officer 2025-04-01 Grant or award · Stock Option (right to buy) +125,180 125,180 D
Loading xslF345X05/wk-form4_1743713294.xml…